BIO.News Newsletter

BIO Investor Forum Digital begins today—and we give you a sneak peek at what you’ll hear from both investors and emerging companies, as well as tell you how to follow along. We also take a closer look at COVID-19 and the world’s plastic problem and what’s happening in Washington. Here are around 785 words, just under 4 minutes.

BIO Investor Forum Digital kicks off tomorrow—and to get ready, Dr. Michelle talks to a biotech investor about everything from COVID-19 therapeutics and diagnostics to the impact of drug pricing policy on investors’ decision-making. Also, POET explains how biofuels can help farmers and the environment. Here are around 840 words, just over 4 minutes.

There’s been a lot of chatter about breakthrough coronavirus treatments this week—so today, we tell you how novel therapies come about in the United States. (No, it’s not magic.) And since we’re still excited about the Nobel Prize for Chemistry, we take a look at CRISPR’s potential in industrial biotech and biofuels. Here are 830 words, 4 minutes.

Today, we dig into the SCOTUS case addressing pharmacy benefit managers, and explain why we need to fix this system. Also, meet the winners of the Nobel Prize in Chemistry and learn why their technology is so important to human, animal, and environmental health. Here’s your Thursday news in 900 words, 4 and a half minutes.

Days after we sent a letter about it to the Trump administration, the U.S. Food and Drug Administration (FDA) released new guidance related to COVID-19 vaccines, bringing clarity to scientists and strengthening public confidence in the process. We have details, plus a look at two BIO members collaborating to develop biofuels and biochemicals, in around 711 words, 3 and a half minutes.

Today, we tell you about why you should support the Growing Climate Solutions Act and how you can help. We also dig into new health care spending data that sheds more light on the true role of prescription drug costs. Here are around 700 words, 3 minutes.

Our thoughts are with the First Family as President Trump continues his COVID-19 treatment at Walter Reed. We're also incredibly proud of our members who have been working hard for months to develop therapeutics that have provided hope for the President and many others around the world battling this disease.Today, we look at a framework for vaccine allocation and distribution, the state of biotech investment, and a biotech insect that could help save crops in around 950 words, just under 5…

So much for a slow Friday. Our thoughts are with President Trump, the First Lady, and their family, and we hope they experience a speedy recovery. Ahead of his testimony on Capitol Hill, BIO sent a letter to Health and Human Services Secretary Alex Azar urging him to release pending vaccine clinical trial guidance. We also explain why it’s important for policy to support plant and animal biotech innovation. Today’s news in about 1,000 words, 5 minutes.

You made it through September. We’re starting the month thinking about how we should talk about science—including how we can boost and commercialize animal biotech innovation, and the importance of having pride in the scientific process, especially as it relates to COVID-19 technologies. Here are around 830 words, 4 minutes.

Today, we have an update on the coronavirus pipeline, plus the role synbio is playing in fighting the virus. Read to the end for our thoughts on the debate. Here are around 730 words, just under 4 minutes.